易瑞生物：易瑞创投、朱海拟分别减持0.88%和1.87%公司股份

Core Viewpoint - The company, Erye Biological (300942), announced that its controlling shareholder, Erye (Hainan) Venture Capital Co., Ltd., plans to reduce its holdings by up to 3.5312 million shares, accounting for 0.88% of the total share capital. The actual controller, Zhu Hai, plans to reduce his holdings by up to 7.5214 million shares, representing 1.87% of the total share capital. The reduction will occur through centralized bidding or block trading from July 28, 2025, to October 27, 2025, due to personal funding needs [1] Summary by Category - Shareholder Reduction Plans - Erye (Hainan) Venture Capital Co., Ltd. intends to reduce its stake by up to 3.5312 million shares, which is 0.88% of the total share capital [1] - Zhu Hai plans to reduce his stake by up to 7.5214 million shares, representing 1.87% of the total share capital [1] - Reduction Method and Timeline - The reduction will be executed through centralized bidding or block trading [1] - The reduction period is set from July 28, 2025, to October 27, 2025 [1] - Reason for Reduction - The reason for the reduction is stated as personal funding needs [1]